Elimination of residual metastatic prostate cancer after surgery and adjunctive cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) blockade immunotherapy

Proceedings of the National Academy of Sciences of the United States of America

Volumn 96, Issue 26, 1999, Pages 15074-15079

  Kwon, Eugene D ^a,d   Foster, Barbara A ^b   Hurwitz, Arthur A ^c   Madias, Chris ^a   Allison, James P ^c   Greenberg, Norman M ^b   Burg, Maurice B ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOCKING ANTIBODY; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CANCER RECURRENCE; CONTROLLED STUDY; LYMPH NODE METASTASIS; MALE; METASTASIS; MINIMAL RESIDUAL DISEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY;

ANIMALS; ANTIBODIES; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; CHEMOTHERAPY, ADJUVANT; IMMUNOCONJUGATES; IMMUNOTHERAPY; LYMPHATIC METASTASIS; MALE; MICE; MICE, INBRED C57BL; PROSTATIC NEOPLASMS;

ANIMALIA; MURINAE;

EID: 0033592924     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.96.26.15074     Document Type: Article

References (25)